Gastrointestinal Stromal Tumors (GIST)
Gastrointestinal Stromal Tumors (GIST) Novartis Oncology
Email This PagePrint This Page

Find a Blood Level Testing Lab
Gastrointestinal Stromal Tumors (GIST)
Gastrointestinal Stromal Tumors (GIST)
Search:

GIST ALLIANCE provides easy access to GLIVEC blood level testing

Glivec blood level testing will help identify patients that may have a lower probability of achieving an optimal outcome.

GLIVEC plasma trough levels above 1100 ng/mL have been shown to correlate with significantly better clinical outcomes1,2

Blood level testing for patients with GIST may help optimize clinical benefit from GLIVEC1,2
 
North America Europe Asia Australia
 
USA
www.gistalliance.com		 Europe
click here		 China
click here		 Australia
www.gistalliance.com.au
 
Canada
click here		 Middle East & Africa Hong Kong
click here		  
 
South America Jordan
click here		 Thailand
click here		  
 
Argentina
click here		 Isreal
click here		 Singapore
click here		  
 
  South Africa
click here		 Taiwan
click here		  
 
  Turkey
click here		 South Korea
click here		  
 

References:
1.
Demetri GD, Wang Y, Wehrle E, Blanke C, Joensuu H, von Mehren M. Correlation of imatinib plasma levels with clinical benefit in patients (Pts) with unresectable/metastatic gastrointestinal stromal tumors (GIST). Presented at: ASCO Gastrointestinal Cancers Symposium; January 25-27, 2008; Orlando, FL. Abstract 3 and Slides.
2.
von Mehren M, Wang Y, Joensuu H, Blanke CD, Wehrle E, Demetri GD. Imatinib pharmacokinetics (PK) and its correlation with clinical response in patients with unresectable/metastatic gastrointestinal stromal tumor (GIST). J Clin Oncol. 2008;26(suppl):Abstract 4523.
Gastrointestinal Stromal Tumors (GIST) © 2010 Novartis AG Home | Glivec Blood Level Testing | Find a Blood Level Testing Lab | About Novartis Oncology | Tell a Colleague
Contact | Site Map | Terms of Use | Privacy Policy		 Gastrointestinal Stromal Tumors (GIST)